期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

采用动态血糖监测评价二甲双胍联合胰岛素治疗对血糖的影响 被引量：1

下载PDF
导出
摘要 胰岛β细胞分泌功能异常和胰岛素抵抗是糖尿病发生、发展的主要机制，而高血糖是加重胰岛β细胞功能衰竭和胰岛素抵抗的主要因素。长期暴露于高血糖环境中，糖尿病患者的大血管和微血管并发症会随之增加。及早启动胰岛素治疗可促进胰岛β细胞功能的恢复，延缓糖尿病并发症的来临。然而目前无论使用何种胰岛素治疗，都存在血糖波动过大及低血糖的风险。
作者 王雅萍 路丽
机构地区 太原市人民医院内分泌科
出处 《中国药物与临床》 CAS 2013年第10期1339-1340,共2页 Chinese Remedies & Clinics
关键词 胰岛素治疗 高血糖 二甲双胍 胰岛Β细胞功能衰竭 糖尿病并发症 胰岛素抵抗 测评 微血管并发症
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献5

二级参考文献11

  • 1喻明,周健,项坤三,陆惠娟,马晓静,陆蔚.动态监测糖耐量正常者血糖水平的漂移变化[J].中华医学杂志,2004,84(21):1788-1790. 被引量：50
  • 2Service FJ, Molnar GD, Rosevear JW, et al. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes, 1970,19:644-655.
  • 3Molnar GD, Taylor WF, Ho MM. Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability. Diabetologia, 1972,8:342-348.
  • 4Selam JL. How to measure glycemic instability? Diabetes Metab, 2000,26:148-151.
  • 5Muggeo M, Verlato G, Bonora E, et al. Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study. Circulation, 1997,96:1750-1754.
  • 6Risso A, Mercuri F, Quagliaro L, et al. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture.Am J Physiol Endocrinol Metab, 2001,281 :E924-E930.
  • 7Yu JG,Javorschi S,Hevener AL,et al.The effect of thiazolidinediones on plasma adiponectin levels in normal,obese and type 2 diabetic subjects.Diabetes,2002,51:2968-2974.
  • 8Boden G,Cheung P,Mozzoli M,et al.Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes.Metabolism,2003,52:753-759.
  • 9Stumoll M,Gerich J.Clinical features of insulin resistance and beta cell dysfunction and the relationship to type 2 diabetes.Clin Lab Met,2001,21:31-51.
  • 10Lebovitz HE,Dole JF,Patwardhan R,et al.Rosiglitazone monotherapy is effective in patients with type 2 diabetes.J Clin Endocrinol Metab,2000,86:280-288.

共引文献428

同被引文献17

  • 1伍华,陈敏,邵丽香,等.西格列汀联合二甲双胍治疗初发2型糖尿病的临床观察[J].中国医药,2013,8(z1):18-19.
  • 2Kelly AS, Bergenstal RM, Gonzalez-Campoy JM, et al. Effects of exenatide vs. metformin on endothelial function in obese patients with pre-diabetes: a randomized trial[J]. Cardiovasc Diabetol, 2012, 11: 64.
  • 3Nadeau DA. Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: the metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach[J]. Postgrad Med, 2013, 125(3): 112-126.
  • 4Kato Y, Koide N, Komatsu T, et al. Metformin attenuates production of nitric oxide in response to lipopolysaccharide by inhibiting MyD88-independent pathway[J]. Honn Metab Res, 2010, 42(9): 632-636.
  • 5Cheng AY, Fantus IG. Oral antihyperglycemic therapy for type 2 diabetes mellitus[J]. CMAJ, 2005, 172(2): 213-226.
  • 6Dunn CJ, Peters DH. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus[J]. Drugs, 1995, 49(5): 721-749.
  • 7A1-Khalili L, Forsgren M, Kannisto K, et al. Enhanced insulin- stimulated glycogen synthesis in response to insulin, metformin or.rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma co- activator l[J]. Diabetologia, 2005, 48(6): 1173-1179.
  • 8Thakkar B, Aronis KN, Vamvini MT, et al. Metformin and sulfonylureas in relation to cancer risk in type lI diabetes patients: a meta-analysis using primary data of published studies [J]. Metabolism, 2013, 62(7): 922-934.
  • 9张丹丹,刘芳.二甲双胍的多重抗癌机制[J].中华医学杂志,2013,93(12):956-958. 被引量：7
  • 10安慧杰,洪天配,王产,魏蕊,刘烨,杨进,张琳.二甲双胍对波动性高糖诱导的内皮细胞功能障碍的逆转作用及其机制[J].中华糖尿病杂志,2013,5(4):231-234. 被引量：7

引证文献1

二级引证文献2

中国药物与临床
2013年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部